We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, EMA Collaborating to Create Harmonized Biosimilars Review Path
FDA, EMA Collaborating to Create Harmonized Biosimilars Review Path
July 19, 2011
CHICAGO — The FDA and European Medicines Agency (EMA) have agreed to work together toward harmonizing biosimilars regulations, which may help the FDA catch up in its development of an abbreviated pathway to approve the generic biologics.